June 10 is International NASH Day, a day where doctors and researchers try to raise awareness and visibility about a prevalent and serious health condition that is only expected to worsen over the next twenty years.  While many people may not be familiar with NASH, doctors say it is important to raise awareness and decrease risk factors for this potentially fatal disease.

NASH, or non-alcoholic steatohepatitis, is a form of non-alcoholic fatty liver disease (NAFLD), which is the leading cause of end-stage liver diseases worldwide.  According to a recent report, experts predict NASH will increase by 63% over the next twenty years.  

Steve Lack, a patient at Saint Luke’s Liver Disease Management, talks to KSHB about his journey with NASH, why he participated in a clinical trial for NASH, and why he still comes to Dr. Laura Alba, Medical Director of Hepatology, even though he moved nearly three hours away. 


Related Content

Jun. 10, 2021

KCTV: Saint Luke's Doctor Raises Awareness for NASH

Dr. Laura Alba, Medical Director of Hepatology, Saint Luke’s Liver Disease Management, talks to KCTV about what NASH is, how NASH affects patients, and why research for NASH is so important.
Apr. 28, 2021

KMBC: Kansas City surgeon says he's seeing more people with acute liver disease in pandemic

A study about stress in America finds 1 in 4 adults is drinking more as a way to cope during the pandemic.
Oct. 16, 2013

Fatty liver disease stronger independent indicator of cardiovascular disease than age, smoking, gender, or other traditional risk factors

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States and other Western countries, affecting up to a thir